YD Bio Limited ("YD Bio" or the "Company") (Nasdaq: YDES), a biotechnology company advancing DNA methylation–based cancer detection technology and ophthalmologic innovations, today announced the publication of a peer-reviewed review article in Nutrients, an international open-access journal published by MDPI (Multidisciplinary Digital Publishing Institute). The article, titled "Beyond Bone Health: Exploring the ‘Heart–Brain–Bone’ Axis Modulated by Lipid-Soluble Nutrients (Omega-3, Vitamin D3, and Vitamin K2)," was co-authored by members of the Company’s scientific team together with physicians associated with the Taiwan Chronic Disease Healthcare Association ("CDHA"), the Future Health Institute ("FHI"), and the Department of Neurosurgery at Taipei Medical University Hospital, among others.